Lower limit of normal or FEV1/FVC <0.70 in diagnosing COPD: An evidence-based review

Respiratory Medicine

Volumn 105, Issue 6, 2011, Pages 907-915

  Mohamed Hoesein, Firdaus A A ^a   Zanen, Pieter ^a   Lammers, Jan Willem J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

COPD; FEV1 FVC; Lower limit of normal (LLN); Review; Spirometry

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COCHRANE LIBRARY; CONTROLLED STUDY; EMBASE; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GOLD STANDARD; HOSPITALIZATION; HUMAN; LOWER LIMIT OF NORMAL; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT PARAMETERS; SPIROMETRY; STANDARD;

AGED; EVIDENCE-BASED MEDICINE; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; VITAL CAPACITY;

EID: 79955465998     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.01.008     Document Type: Article

References (39)

1. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study Lancet 349 1997 1498 1504 (Pubitemid 27216360)
2. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, W.C. van, and J. Zielinski Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555 (Pubitemid 47403272)
3. J.C. Hogg Pathophysiology of airflow limitation in chronic obstructive pulmonary disease Lancet 364 2004 709 721 (Pubitemid 39140629)
4. R. Pellegrino, V. Brusasco, G. Viegi, R.O. Crapo, F. Burgos, R. Casaburi, A. Coates, C.P. van der Grinten, P. Gustafsson, J. Hankinson, R. Jensen, D.C. Johnson, N. Macintyre, R. McKay, M.R. Miller, D. Navajas, O.F. Pedersen, and J. Wanger Definition of COPD: based on evidence or opinion? Eur Respir J 31 2008 681 682
5. M.R. Miller, O.F. Pedersen, R. Pellegrino, and V. Brusasco Debating the definition of airflow obstruction: time to move on? Eur Respir J 34 2009 527 528
6. D.M. Mannino Defining chronic obstructive pulmonary disease and the elephant in the room Eur Respir J 30 2007 189 190 (Pubitemid 47194169)
7. R.A. Pauwels, A.S. Buist, P.M. Calverley, C.R. Jenkins, and S.S. Hurd Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am J Respir Crit Care Med 163 2004 1256 1276
8. B.R. Celli, and W. MacNee Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 2004 932 946 (Pubitemid 38807371)
9. J.P. Janssens, J.C. Pache, and L.P. Nicod Physiological changes in respiratory function associated with ageing Eur Respir J 13 1999 197 205 (Pubitemid 29079244)
10. Oxford Centre for Evidence-based Medicine (CEBM) Levels of evidence http://www.cebm.net 2009 [accessed September 2009]
11. S.W. Ra, J.S. Oh, S.B. Hong, T.S. Shim, C.M. Lim, Y.S. Koh, S.D. Lee, W.S. Kim, D.S. Kim, W.D. Kim, and Y.M. Oh Effect of the changing the lower limits of normal and the interpretative strategies for lung function tests Tuberc Respir Dis 61 2006 129 136 (Pubitemid 44831545)
12. G.L. Ruppel Spirometric determination of chronic obstructive pulmonary disease J Organ Dysfunct 3 2007 221 223 (Pubitemid 350058928)
13. M.L. Margolis, F.J. Montoya, and W.R. Palma Jr. Pulmonary function tests: comparison of 95th percentile-based and conventional criteria of normality South Med J 90 1997 1187 1191 (Pubitemid 27528356)
14. T.R.J. Schermer, I.J.M. Smeele, B.P.A. Thoonen, A.E.M. Lucas, J.G. Grootens, T.J. Van Boxem, Y.F. Heijdrae, and C. Van Weel Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care Eur Respir J 32 2008 945 952
15. Y.I. Hwang, C.H. Kim, H.R. Kang, T. Shin, S.M. Park, S.H. Jang, Y.B. Park, C.H. Kim, D.G. Kim, M.G. Lee, I.G. Hyun, and K.S. Jung Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria J Korean Med Sci 24 2009 621 626
16. F.W.S. Ko, J. Woo, W. Tam, C.K.W. Lai, J. Ngai, T. Kwok, and D.S.C. Hui Prevalence and risk factors of airflow obstruction in an elderly Chinese population Eur Respir J 32 2008 1472 1478
17. P. Shirtcliffe, M. Weatherall, S. Marsh, J. Travers, A. Hansell, A. McNaughton, S. Aldington, H. Muellerova, and R. Beasley COPD prevalence in a random population survey: a matter of definition Eur Respir J 30 2007 232 239 (Pubitemid 47194175)
18. W.M. Vollmer, T. Gislason, P. Burney, P.L. Enright, A. Gulsvik, A. Kocabas, and A.S. Buist Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study Eur Respir J 34 2009 588 597
19. R. Perez-Padilla, P.C. Hallal, J.C. Vazquez-Garcia, A. Muino, M. Maquez, M.V. Lopez, M.M. de Oca, C. Talamo, G. Valdivia, J. Pertuze, J. Jardim, and A.M. Menezes Impact of bronchodilator use on the prevalence of COPD in population-based samples COPD 4 2007 113 120 (Pubitemid 47164863)
20. D.M. Mannino, A.S. Buist, and W.M. Vollmer Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 62 2007 237 241 (Pubitemid 46579804)
21. C.A. Vaz Fragoso, J. Concato, G. McAvay, P.H. Van Ness, C.L. Rochester, H.K. Yaggi, and T.M. Gill Chronic obstructive pulmonary disease in older persons: a comparison of two spirometric definitions Respir Med 104 8 2010 1189 1196
22. A.N. Aggarwal, D. Gupta, D. Behera, and S.K. Jindal Comparison of fixed percentage method and lower confidence limits for defining limits of normality for interpretation of spirometry Respir Care 51 2006 737 743 (Pubitemid 47109295)
23. W. Dejsomritrutai, P. Wongsurakiat, N. Chierakul, S. Charoenratanakul, A. Nana, and K.N. Maranetra Comparison between specified percentage and fifth percentile criteria for spirometry interpretation in Thai patients Respirology 7 2002 123 127 (Pubitemid 34662943)
24. 1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age Chest 130 2006 200 206 (Pubitemid 44116860)
25. B.R. Celli, R.J. Halbert, S. Isonaka, and B. Schau Population impact of different definitions of airway obstruction Eur Respir J 22 2003 268 273 (Pubitemid 36986996)
26. 1/FVC ratio below the fifth percentile, not <70% Chest 131 2007 349 355 (Pubitemid 46280391)
27. E. Hnizdo, H.W. Glindmeyer, E.L. Petsonk, P. Enright, and A.S. Buist Case definitions for chronic obstructive pulmonary disease COPD 3 2006 95 100 (Pubitemid 43739181)
28. A.C. Lau, M.S. Ip, C.K. Lai, K.L. Choo, K.S. Tang, L.Y. Yam, and M. Chan-Yeung Variability of the prevalence of undiagnosed airflow obstruction in smokers using different diagnostic criteria Chest 133 2008 42 48
29. 1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision? Respir Med 102 2008 1568 1574
30. 1/FVC ratio reduces the misclassification of airway obstruction Thorax 63 2008 1046 1051
31. 1 to FVC as a basis for establishing chronic obstructive pulmonary disease Am J Respir Crit Care Med 181 2010 446 451
32. P.N. Valenstein Evaluating diagnostic tests with imperfect standards Am J Clin Pathol 93 1990 252 258 (Pubitemid 20068429)
33. C. Fletcher, and R. Peto The natural history of chronic airflow obstruction Br Med J 1 1977 1645 1648 (Pubitemid 8124466)
34. B. Burrows, R.J. Knudson, A.E. Camilli, S.K. Lyle, and M.D. Lebowitz The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry Am Rev Respir Dis 135 1987 788 793 (Pubitemid 17055502)
35. D.P. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten, S. Menjoge, and M. Decramer A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 2008 1543 1554
36. B.R. Celli, N.E. Thomas, J.A. Anderson, G.T. Ferguson, C.R. Jenkins, P.W. Jones, J. Vestbo, K. Knobil, J.C. Yates, and P.M. Calverley Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study Am J Respir Crit Care Med 178 2008 332 338
37. P.O. Bridevaux, M.W. Gerbase, N.M. Probst-Hensch, C. Schindler, J.M. Gaspoz, and T. Rochat Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD Thorax 63 2008 768 774
38. R. De Marco, S. Accordini, J.M. Anto, T. Gislason, J. Heinrich, C. Janson, D. Jarvis, N. Kunzli, B. Leynaert, A. Marcon, J. Sunyer, C. Svanes, M. Wjst, and P. Burney Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European community respiratory health survey Am J Respir Crit Care Med 180 2009 956 963
39. A. Qaseem, V. Snow, P. Shekelle, K. Sherif, T.J. Wilt, S. Weinberger, and D.K. Owens Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians Ann Intern Med 147 2007 633 638 (Pubitemid 351664484)